By Christoph Steitz, Arno Schuetze and Oliver Hirt FRANKFURT/BERLIN/ZURICH (Reuters) - Japan's Toshiba Corp is preparing a potential $2 billion divestment of smart meter group Landis+Gyr, hoping to rake in capital after a major writedown on its U.S. nuclear ... Sify, 3 weeks ago
ZURICH (Reuters) - Swiss Re, the world's second-largest reinsurer, confirmed its mid-term targets on Thursday even as continued pricing pressure saw its January renewals drop 18 percent. Fourth-quarter net profit fell 45 percent as claims from natural ...Sify, 1 month ago
Confident of bouncing back after enduring a mixed 2016, former world chess champion Viswanathan Anand says he will compete in the Grand Chess Tour, which includes five tournaments and the World Cup, this year. Speaking at the inauguration of a three-day chess ...Business Standard, 1 week ago
Novartis has won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women who have a difficult-to-treat form of breast cancer, challenging U.S. rival Pfizer's Ibrance. The Swiss company has priced Kisqali to be cheaper than ...Reuters, 1 week ago
The Rs 16,000-crore greenfield Navi Mumbai international airport project on Monday moved a step closer to reality a decade after it was cleared, with GVK Group bagging the financial bid to build and operate the facility. GVK Group that runs the swanky MIAL (Mumbai international airport) pipped rival GMR Group to bag the contract for the proposed facility in Navi Mumbai which will ease the severe congestion at the Chhatrapati Shivaji International Airport. The new airport was proposed in 1997 ...Rediff.com, 1 month ago Tata, GMR giving Navi Mumbai Int'l Airport a miss? DNA, 2 months ago
The Novartis copy of Amgen's blockbuster psoriasis drug Enbrel will not go on sale before 2018 at the earliest because of the U.S. company's patent protection challenge, the Swiss drugmaker's head of generics told Reuters. Though the U.S. Food and Drug ...Reuters, 1 month ago
on your WebpageAdd Widget >Get your members hooked!